TNF and breast cancer: In this study, TNFα treatment led to significant over-expression of PTX3 in bone metastatic breast cancer cells, but not in non-bone metastatic breast cancer cells (Figure 2), reinforcing PTX3 as a modulator of breast cancer-related inflammation.